Verona Pharma PLC (VRNA)
38.81
+0.95
(+2.51%)
USD |
NASDAQ |
Nov 22, 16:00
38.79
-0.02
(-0.05%)
After-Hours: 20:00
Verona Pharma Cash from Financing (Quarterly): -7.087M for Sept. 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -7.087M |
| June 30, 2024 | 166.83M |
| March 31, 2024 | -3.123M |
| December 31, 2023 | 24.01M |
| September 30, 2023 | 0.048M |
| June 30, 2023 | 0.124M |
| March 31, 2023 | 68.68M |
| December 31, 2022 | 2.614M |
| September 30, 2022 | 139.62M |
| June 30, 2022 | -0.689M |
| March 31, 2022 | -0.726M |
| December 31, 2021 | -0.901M |
| September 30, 2021 | -1.817M |
| June 30, 2021 | -3.399M |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 3.95M |
| Date | Value |
|---|---|
| September 30, 2020 | 188.39M |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.372M |
| September 30, 2019 | -0.1591M |
| June 30, 2019 | -0.1033M |
| March 31, 2019 | -0.1096M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.742M |
| September 30, 2017 | 2.078M |
| June 30, 2017 | 83.97M |
| March 31, 2017 | -1.321M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-7.087M
Minimum
Sep 2024
188.39M
Maximum
Sep 2020
28.85M
Average
0.024M
Median
Cash from Financing (Quarterly) Benchmarks
| TC BioPharm (Holdings) PLC | 1.183M |
| Adaptimmune Therapeutics PLC | 25.00M |
| Biodexa Pharmaceuticals PLC | -- |
| NuCana PLC | -0.0888M |
| Autolus Therapeutics PLC | 0.185M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -62.66M |
| Free Cash Flow | -103.81M |
| Free Cash Flow Per Share (Quarterly) | -0.7688 |
| Free Cash Flow to Equity (Quarterly) | -62.98M |
| Free Cash Flow to Firm (Quarterly) | -57.49M |
| Free Cash Flow Yield | -3.31% |